Emperra
Bluetooth-enable insulin pen and a wireless blood glucose meter to monitor diabetes patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Emperra GmbH E Health Technologies operates in the digital health sector, focusing on innovative solutions for diabetes management. The company's flagship product, ESYSTA, is an automated system that tracks insulin units and blood glucose readings, eliminating the need for manual diary entries. This system integrates seamlessly with an online portal, allowing both patients and healthcare providers to access and manage data in real-time. The ESYSTA app has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) and is reimbursable by all German Sick Funds, making it accessible to a broad range of patients. Emperra's business model revolves around the sale of its ESYSTA product suite, which includes the app, portal, pen, lab, and basis. Revenue is generated through product sales and potentially through partnerships with healthcare providers and insurance companies. The company primarily serves diabetic patients and healthcare providers in Germany, aiming to improve treatment outcomes through better data management and real-time monitoring.
Keywords: diabetes management, insulin tracking, glucose monitoring, digital health, ESYSTA app, BfArM approval, German Sick Funds, real-time data, healthcare providers, automated system.